Healthcare Management

A National Cancer Clinical Trials System for the 21st Century

---

Advances in biomedical research are yielding significant opportunities to improve cancer prevention, detection, and treatment. However, the ability to translate biomedical discoveries into meaningful advances in cancer care depends on an effective clinical trials system. Publicly funded clinical trials play a vital role by addressing questions that are important to patients but are less likely to be top priorities of industry, which has an important primary focus on new drug development and Food and Drug Administration (FDA) registration. For example, companies may have less incentive to
• conduct clinical trials to compare the effectiveness of different treatment options that are already approved for clinical use, • combine novel therapies developed by different sponsors, • develop therapies for rare diseases, • determine optimal duration and dose of treatment with drugs in clinical use, • test multimodality therapies, such as radiation therapy, surgery, or devices in combination with drugs, • study screening and prevention strategies, or • focus on rehabilitation and quality of life following therapy.
The National Cancer Institute (NCI) supports the largest U.S. network for clinical trials of any type.

---

Availability

No copy data

Detail Information

Series Title

-

Call Number

-

Publisher

: ., 2010

Collation

1-317

Language

English

ISBN/ISSN

978-0-309-15186-3

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

A National Cancer Clinical Trials System for the 2

Specific Detail Info

-

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment